Elutia (ELUT) Liabilities from Discontinued Operations (2022 - 2025)

Elutia (ELUT) reported Liabilities from Discontinued Operations of 357000.0 for Q3 2025, up 13.33% sequentially from 315000.0 in Q4 2024.

Elutia (ELUT) Liabilities from Discontinued Operations (2022 - 2025) Analysis & Trends

Elutia (ELUT) has 4 years of Liabilities from Discontinued Operations data on file, last reported at 357000.0 in Q3 2025.

  • For the quarter ending Q3 2025, Liabilities from Discontinued Operations changed N/A year-over-year to 357000.0; the trailing twelve-month figure through Sep 2025 stood at 357000.0 (changed N/A YoY), and the FY2024 full-year result was 315000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations grew to 357000.0 in Q3 2025, from 315000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 4929000.0 in Q4 2022 to a low of 315000.0 in Q4 2024.
  • A 4-year average of 2197750.0 and a median of 1773500.0 in 2023 frame the typical range for Liabilities from Discontinued Operations.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Elutia 39.99 Mn 11.50 Mn 1.80 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 357,000.00
Sep 30, 2025 357,000.00
Dec 31, 2024 315,000.00
Dec 31, 2024 315,000.00
Sep 30, 2023 3.19 Mn
Sep 30, 2023 3.19 Mn
Dec 31, 2022 4.93 Mn
Dec 31, 2022 4.93 Mn